Lakewood, OH
Stem Cell Therapy clinics in Lakewood
Lakewood supports a regenerative medicine market shaped by both private clinics and regional academic medicine. Local referral networks run through St. Anthony Hospital and nearby UCHealth, and stem cell practice in the area spans Belmar, Union Boulevard, and the Green Mountain corridor. Patient demand splits across three buckets: orthopedic injections for active adults and aging athletes, neurological and autoimmune protocols marketed to longevity-focused patients, and IV-based allogeneic products offered by private wellness clinics. The FDA classifies most stem cell injections for orthopedic, neurological, or longevity use as investigational biologics under 21 CFR Part 1271, meaning they require either a Biologics License or an active Investigational New Drug authorization. Autologous bone marrow and adipose products may qualify as Section 361 when minimally manipulated and used for homologous function. Colorado regulates physician practice through the Colorado Medical Board. There is no state-specific stem cell disclosure law, so federal 21 CFR Part 1271 rules apply. The state has a strong regenerative orthopedic research presence around Denver and Boulder. The 3 Lakewood clinics listed below have been reviewed against our vetting criteria, including federal NPI lookup, OIG exclusion screening, and Colorado Medical Board licensure checks.
No clinics found
Reset all filtersRegulatory context
A note on Ohio's stem cell therapy rules.
Ohio cellular therapy is governed by 21 CFR Part 1271. Section 361 covers minimally manipulated HCT/Ps used for homologous use without premarket approval. Section 351 covers products that are more than minimally manipulated, used non-homologously, or combined with another article, and these require an IND for clinical use or a BLA for marketing. Most stem cell, stromal vascular fraction, and exosome therapies marketed in Ohio for orthopedic, neurologic, and longevity indications are Section 351 biologics that lack FDA approval. Ohio hosts substantial academic regenerative medicine research at Case Western and Cleveland Clinic.
-
Ohio Medical Practice Act, Ohio Revised Code Chapter 4731
Establishes physician licensure and discipline through the State Medical Board of Ohio. -
Ohio Pharmacy Practice Act, Ohio Revised Code Chapter 4729
Regulates compounding pharmacies aligned with federal 503A and 503B standards. -
Ohio Consumer Sales Practices Act, Ohio Revised Code Chapter 1345
Empowers the Attorney General and private plaintiffs to pursue deceptive marketing claims against providers making unsupported clinical claims.
The FDA has issued warning letters to Ohio clinics offering stem cell and exosome therapies. The State Medical Board of Ohio has disciplined physicians for unprofessional conduct including misleading regenerative medicine advertising. The Ohio Attorney General has used the Consumer Sales Practices Act to pursue providers making unsupported clinical claims. Ohio's combination of academic IND-based research and direct-to-patient regenerative clinics produces a mixed compliance landscape.
Stem Cell Therapy in Lakewood, answered.
Explore related care